Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

Similar articles for PubMed (Select 18623215)

1.

Late effects in survivors of tandem peripheral blood stem cell transplant for high-risk neuroblastoma.

Hobbie WL, Moshang T, Carlson CA, Goldmuntz E, Sacks N, Goldfarb SB, Grupp SA, Ginsberg JP.

Pediatr Blood Cancer. 2008 Nov;51(5):679-83. doi: 10.1002/pbc.21683.

2.

Impact of TBI on late effects in children treated by megatherapy for Stage IV neuroblastoma. A study of the French Society of Pediatric oncology.

Flandin I, Hartmann O, Michon J, Pinkerton R, Coze C, Stephan JL, Fourquet B, Valteau-Couanet D, Bergeron C, Philip T, Carrie C.

Int J Radiat Oncol Biol Phys. 2006 Apr 1;64(5):1424-31. Epub 2006 Jan 19.

PMID:
16427213
3.

High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma.

Yalçin B, Kremer LC, Caron HN, van Dalen EC.

Cochrane Database Syst Rev. 2013 Aug 22;8:CD006301. doi: 10.1002/14651858.CD006301.pub3. Review.

PMID:
23970444
4.
5.

Long-term follow-up of pediatric patients receiving total body irradiation before hematopoietic stem cell transplantation and post-transplant survival of >2 years.

Künkele A, Engelhard M, Hauffa BP, Mellies U, Müntjes C, Hüer C, Eggert A, Schulte JH, Kremens B.

Pediatr Blood Cancer. 2013 Nov;60(11):1792-7. doi: 10.1002/pbc.24702. Epub 2013 Jul 24.

PMID:
23893964
6.

High-risk neuroblastoma treated with tandem autologous peripheral-blood stem cell-supported transplantation: long-term survival update.

George RE, Li S, Medeiros-Nancarrow C, Neuberg D, Marcus K, Shamberger RC, Pulsipher M, Grupp SA, Diller L.

J Clin Oncol. 2006 Jun 20;24(18):2891-6.

7.

Treatment of high-risk neuroblastoma with triple-tandem high-dose therapy and stem-cell rescue: results of the Chicago Pilot II Study.

Kletzel M, Katzenstein HM, Haut PR, Yu AL, Morgan E, Reynolds M, Geissler G, Marymount MH, Liu D, Kalapurakal JA, Shore RM, Bardo DM, Schmoldt J, Rademaker AW, Cohn SL.

J Clin Oncol. 2002 May 1;20(9):2284-92.

PMID:
11980999
8.
9.

Thiotepa and melphalan based single, tandem, and triple high dose therapy and autologous stem cell transplantation for high risk neuroblastoma.

Saarinen-Pihkala UM, Hovi L, Koivusalo A, Jahnukainen K, Karikoski R, Sariola H, Wikström S.

Pediatr Blood Cancer. 2012 Dec 15;59(7):1190-7. doi: 10.1002/pbc.24173. Epub 2012 Apr 10.

PMID:
22492714
10.

Late effects in children treated with intensive multimodal therapy for high-risk neuroblastoma: high incidence of endocrine and growth problems.

Cohen LE, Gordon JH, Popovsky EY, Gunawardene S, Duffey-Lind E, Lehmann LE, Diller LR.

Bone Marrow Transplant. 2014 Apr;49(4):502-8. doi: 10.1038/bmt.2013.218. Epub 2014 Jan 20.

PMID:
24442245
11.

1070 myeloablative megatherapy procedures followed by stem cell rescue for neuroblastoma: 17 years of European experience and conclusions. European Group for Blood and Marrow Transplant Registry Solid Tumour Working Party.

Philip T, Ladenstein R, Lasset C, Hartmann O, Zucker JM, Pinkerton R, Pearson AD, Klingebiel T, Garaventa A, Kremens B, Bernard JL, Rosti G, Chauvin F.

Eur J Cancer. 1997 Oct;33(12):2130-5.

PMID:
9516868
12.

Tandem high-dose chemotherapy and autologous stem cell transplantation in patients with high-risk neuroblastoma: results of SMC NB-2004 study.

Sung KW, Son MH, Lee SH, Yoo KH, Koo HH, Kim JY, Cho EJ, Lee SK, Choi YS, Lim DH, Kim JS, Kim DW.

Bone Marrow Transplant. 2013 Jan;48(1):68-73. doi: 10.1038/bmt.2012.86. Epub 2012 May 28.

PMID:
22635247
13.

Long-term complications in survivors of advanced stage neuroblastoma.

Laverdière C, Cheung NK, Kushner BH, Kramer K, Modak S, LaQuaglia MP, Wolden S, Ness KK, Gurney JG, Sklar CA.

Pediatr Blood Cancer. 2005 Sep;45(3):324-32.

PMID:
15714447
14.

Myeloablative therapy and bone marrow rescue in advanced neuroblastoma. Report from the Italian Bone Marrow Transplant Registry. Italian Association of Pediatric Hematology-Oncology, BMT Group.

Garaventa A, Rondelli R, Lanino E, Dallorso S, Dini G, Bonetti F, Arrighini A, Santoro N, Rossetti F, Miniero R, Andolina M, Amici A, Indolfi P, Lo Curto M, Favre C, Paolucci P, Pession A, De Bernardi B.

Bone Marrow Transplant. 1996 Jul;18(1):125-30.

PMID:
8832005
15.

[Long-term effect of high dose chemotherapy combined with stem cell transplantation on stage IV neuroblastoma in children].

Tang SQ, Huang DS, Wang JW, Feng C, Yang G.

Zhongguo Dang Dai Er Ke Za Zhi. 2006 Apr;8(2):93-6. Chinese.

PMID:
16613697
16.

Improved survival of children with advanced neuroblastoma treated by intensified therapy including myeloablative chemotherapy with stem cell transplantation: a retrospective analysis from the Tohoku Neuroblastoma Study Group.

Imaizumi M, Watanabe A, Kikuta A, Takano T, Ito E, Shimizu T, Tsuchiya S, Iinuma K, Konno T, Ohi R, Hayashi Y; Tohoku Neuroblastoma Study Group.

Tohoku J Exp Med. 2001 Oct;195(2):73-83.

17.

Primary tumor control in patients with stage 3/4 unfavorable neuroblastoma treated with tandem double autologous stem cell transplants.

Marcus KJ, Shamberger R, Litman H, von Allmen D, Grupp SA, Nancarrow CM, Goldwein J, Grier HE, Diller L.

J Pediatr Hematol Oncol. 2003 Dec;25(12):934-40.

PMID:
14663275
18.

Growth in children with poor-risk neuroblastoma after regimens with or without total body irradiation in preparation for autologous bone marrow transplantation.

Hovi L, Saarinen-Pihkala UM, Vettenranta K, Lipsanen M, Tapanainen P.

Bone Marrow Transplant. 1999 Nov;24(10):1131-6.

19.

Role of busulfan and total body irradiation on growth of prepubertal children receiving bone marrow transplantation and results of treatment with recombinant human growth hormone.

Giorgiani G, Bozzola M, Locatelli F, Picco P, Zecca M, Cisternino M, Dallorso S, Bonetti F, Dini G, Borrone C, et al.

Blood. 1995 Jul 15;86(2):825-31.

20.

Neuroblastoma, childhood cancer survivorship, and reducing the consequences of cure.

Gurney JG.

Bone Marrow Transplant. 2007 Oct;40(8):721-2. No abstract available.

PMID:
17912265
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk